1-7 of 7
Richard L Klein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes

Free
Nathaniel L. Baker, Kelly J. Hunt, Danielle R. Stevens, Gabor Jarai, Glenn D. Rosen, Richard L. Klein, Gabriel Virella, Maria F. Lopes-Virella, the DCCT/EDIC Research Group
Journal: Diabetes Care
Diabetes Care 2018;41(1):128–135
https://doi.org/10.2337/dc17-0867
Published: 08 November 2017
View articletitled, Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes
Open the PDF for Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications

Free
Maria F. Lopes-Virella, MD, PHD, Rickey E. Carter, PHD, Gregory E. Gilbert, MS, Richard L. Klein, PHD, Miran Jaffa, PHD, Alicia J. Jenkins, MD, Timothy J. Lyons, MD, W. Timothy Garvey, MD, Gabriel Virella, MD, PHD, and the DCCT/EDIC Cohort Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(10):2006–2012
https://doi.org/10.2337/dc08-0659
Published: 01 October 2008
View articletitled, Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Open the PDF for Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications in another window
Includes: Supplementary data
Journal Articles

Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia

Free
Youlian Liao, PHD, Soonho Kwon, MD, Sara Shaughnessy, MS, RD, Penny Wallace, MS, RN, Amy Hutto, RN, Alicia J. Jenkins, MD, Richard L. Klein, PHD, W. Timothy Garvey, MD
Journal: Diabetes Care
Diabetes Care 2004;27(4):978–983
https://doi.org/10.2337/diacare.27.4.978
Published: 01 April 2004
View articletitled, Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia
Open the PDF for Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia in another window
Journal Articles

Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort

Free
Richard L. Klein, PHD, Steven J. Hunter, MD, Alicia J. Jenkins, MD, Deyi Zheng, MD, PHD, Andrea J. Semler, MT (ASCP), Jennifer Clore, W. Timothy Garvey, MD, The DCCT/EDIC Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(5):1439–1448
https://doi.org/10.2337/diacare.26.5.1439
Published: 01 May 2003
View articletitled, Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort
Open the PDF for Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort in another window
Journal Articles

Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia

Free
Alicia J. Jenkins, MD, Timothy J. Lyons, MD, Deyi Zheng, MD, PHD, James D. Otvos, PHD, Daniel T. Lackland, PHD, Daniel McGee, PHD, W. Timothy Garvey, MD, Richard L. Klein, PHD, The DCCT/EDIC Research Group
Journal: Diabetes Care
Diabetes Care 2003;26(3):810–818
https://doi.org/10.2337/diacare.26.3.810
Published: 01 March 2003
View articletitled, Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia
Open the PDF for Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia in another window
Journal Articles

Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes

Free
Rudolf Jokl, MD, Richard L Klein, PHD, Maria F Lopes-Virella, MD, PHD, John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1995;18(8):1150–1155
https://doi.org/10.2337/diacare.18.8.1150
Published: 01 August 1995
View articletitled, Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes
Open the PDF for Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes in another window
Journal Articles

Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes

Free
Rudolf Jokl, MD, Marta Laimins, Richard L Klein, PHD, Timothy J Lyons, MD, MRCP, Maria F Lopes-Virella, MD, PHD, John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(8):818–823
https://doi.org/10.2337/diacare.17.8.818
Published: 01 August 1994
View articletitled, Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes
Open the PDF for Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes in another window